文献速递神经肿瘤

胶质母细胞瘤生存率与病例量的差异:一项全国性观察性研究

Disparities in glioblastoma survival by case volume: a nationwide observational study.
PubMed 文献 · J Neurooncol · 2020-02-14

该研究基于芬兰全国癌症登记数据,纳入2000至2013年确诊的2045例成人胶质母细胞瘤患者,按年病例量将五所大学医院分为高、中、低容量组,比较生存率与死亡相对超额风险。结果显示高容量和中容量医院的1年生存率及中位生存期高于低容量医院,低容量医院死亡相对超额风险高于高容量医院。

要点

  • 高容量医院年均可治疗54例,中容量40例,低容量17例。
  • 高容量医院1年生存率39%、中位生存9.3个月;中容量38%、8.9个月;低容量32%、7.8个月。
  • 低容量医院较高容量医院死亡相对超额风险升高(RER=1.19,95%CI 1.07-1.32,p=0.002)。

核心结论

  • 较高的胶质母细胞瘤病例量与更好的生存相关。
  • 未来研究应评估该关联是否源于患者个体因素或治疗质量的差异。

研究设计与样本

  • 全国性观察性研究,基于芬兰全国癌症登记数据,纳入2000至2013年经组织病理学诊断的成人(≥18岁)胶质母细胞瘤患者,共2045例。
  • 五所大学医院(治疗芬兰所有胶质母细胞瘤患者)按年病例量分为高容量(1所)、中容量(1所)和低容量(3所)。

主要发现

  • 高、中、低容量医院年均治疗患者数分别为54例、40例和17例。
  • 高容量医院1年生存率39%、中位生存期9.3个月;中容量医院38%、8.9个月;低容量医院32%、7.8个月。
  • 低容量医院较高容量医院死亡相对超额风险升高(RER=1.19,95%CI 1.07-1.32,p=0.002)。
  • 高容量与中容量医院之间死亡相对超额风险无差异(p=0.690)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: High hospital case volumes are associated with improved treatment outcomes for numerous diseases. We assessed the association between academic non-profit hospital case volume and survival of adult glioblastoma patients. METHODS: From the nationwide Finnish Cancer Registry, we identified all adult (≥ 18 years) patients with histopathological diagnoses of glioblastoma from 2000 to 2013. Five university hospitals (treating all glioblastoma patients in Finland) were classified as high-volume (one hospital), middle-volume (one hospital), and low-volume (three hospitals) based on their annual numbers of cases. We estimated one-year survival rates, estimated median overall survival times, and compared relative excess risk (RER) of death between high, middle, and low-volume hospitals. RESULTS: A total of 2,045 patients were included. The mean numbers of annually treated patients were 54, 40, and 17 in the high, middle, and low-volume hospitals, respectively. One-year survival rates and median survival times were higher and longer in the high-volume (39%, 9.3 months) and medium-volume (38%, 8.9 months) hospitals than in the low-volume (32%, 7.8 months) hospitals. RER of death was higher in the low-volume hospitals than in the high-volume hospital (RER = 1.19, 95% CI 1.07-1.32, p = 0.002). There was no difference in RER of death between the high-volume and medium-volume hospitals (p = 0.690). CONCLUSION: Higher glioblastoma case volumes were associated with improved survival. Future studies should assess whether this association is due to differences in patient-specific factors or treatment quality.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Raj R, Seppä K, Luostarinen T, et al. Disparities in glioblastoma survival by case volume: a nationwide observational study. J Neurooncol. 2020. PMID: 32060840. doi:10.1007/s11060-020-03428-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。